Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.
Weinan GuoZhenjie WuJianru ChenSen GuoWeiming YouSijia WangJinyuan MaHuina WangXiangxu WangHao WangJingjing MaYuqi YangYangzi TianQiong ShiTianwen GaoXiuli YiChunying LiPublished in: Journal for immunotherapy of cancer (2022)
MiR-21-3 p upregulation contributes to IFN-γ-driven ferroptosis and synergizes with anti-PD-1 antibody. Nanoparticle delivery of miR-21-3 p is a promising therapeutic approach to increase immunotherapy efficacy without obvious systemic side effects.